Biomaterial business field
In 1986, through research collaboration with BMG, Gunze Ltd. obtained approval from Ministry of Health and Welfare, Japan for producing the first domestically produced bio-absorbable surgical sutures. This triggered BMG production of medical-use bio-absorbable polymer (PGA) for surgical sutures, for the first time domestically.
Thereafter, BMG had stepped forward to PGA production in larger quantities and also have been actively engaged in development and production of various types of bio-absorbable polymer materials. In 1996, production of Poly-L-lactide (PLLA) materials for bio-absorbable bone fixtures was commenced. In 1997, production of Poly (L-lactide-co-ε-caprolactone) (LCL) materials for bio-absorbable monofilament surgical sutures was commenced.
Nowadays, all of these biodegradable and absorbable polymer materials are produced in accordance with ISO 13485 and are supplied globally by the brand name of “BioDegmer”
Application and relevant final products of ”BioDegmer”
“BioDegmer” can be processed into various kinds of forms and applied to wide range of usage in medical fields.
In order to improve patients’ QOL (quality of life), “BioDegmer” is the ideal innovative solutions by its excellent bio-compatibility, bio-absorbability and flexible processing property.
Product information
BMG Inc.
〒601-8023
45 Minamimatsunoki-cho, Higashikujo, Minami-ku, Kyoto 601−8023, JAPAN
+81-75-681-0787
©2024 BMG Inc.